Skip to main content

Table 4 AUC comparison of oncotype alone and then combined with histology grade, clinical data (age, stage, tumor size, and LN pos), AI grade, and the PDxBr model

From: Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years

Model

C-index

CI lower limit

CI upper limit

Oncotype RS

0.35

0.26

0.48

Oncotype + grade

0.51

0.42

0.60

Oncotype + Clinical

0.64

0.57

0.71

Oncotype + AI grade

0.72

0.67

0.79

Oncotype + PDX Br

0.76

0.70

0.82